Cowealth Medical ChinaLtd Past Earnings Performance
Past criteria checks 1/6
Cowealth Medical ChinaLtd's earnings have been declining at an average annual rate of -11.9%, while the Healthcare industry saw earnings growing at 2% annually. Revenues have been declining at an average rate of 1.6% per year. Cowealth Medical ChinaLtd's return on equity is 2.6%, and it has net margins of 3.1%.
Key information
-11.9%
Earnings growth rate
-20.4%
EPS growth rate
| Healthcare Industry Growth | 7.0% |
| Revenue growth rate | -1.6% |
| Return on equity | 2.6% |
| Net Margin | 3.1% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Cowealth Medical ChinaLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 970 | 30 | 151 | 3 |
| 30 Jun 24 | 1,008 | 39 | 147 | 4 |
| 31 Mar 24 | 1,064 | 45 | 157 | 3 |
| 31 Dec 23 | 1,093 | 47 | 156 | 3 |
| 30 Sep 23 | 1,156 | 73 | 145 | 3 |
| 30 Jun 23 | 1,221 | 77 | 147 | 3 |
| 31 Mar 23 | 1,239 | 77 | 152 | 3 |
| 31 Dec 22 | 1,280 | 83 | 150 | 3 |
| 30 Sep 22 | 1,248 | 81 | 153 | 2 |
| 30 Jun 22 | 1,216 | 82 | 152 | 2 |
| 31 Mar 22 | 1,242 | 81 | 150 | 0 |
| 31 Dec 21 | 1,191 | 80 | 142 | 0 |
| 30 Sep 21 | 1,230 | 82 | 125 | 0 |
| 30 Jun 21 | 1,183 | 73 | 123 | 0 |
| 31 Mar 21 | 1,174 | 85 | 126 | 0 |
| 31 Dec 20 | 1,089 | 73 | 126 | 0 |
| 31 Dec 19 | 1,047 | 67 | 141 | 0 |
| 31 Dec 18 | 904 | 67 | 115 | 0 |
| 31 Dec 17 | 680 | 47 | 101 | 0 |
Quality Earnings: 603122 has high quality earnings.
Growing Profit Margin: 603122's current net profit margins (3.1%) are lower than last year (6.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 603122's earnings have declined by 11.9% per year over the past 5 years.
Accelerating Growth: 603122's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 603122 had negative earnings growth (-59.1%) over the past year, making it difficult to compare to the Healthcare industry average (-5.7%).
Return on Equity
High ROE: 603122's Return on Equity (2.6%) is considered low.